Skip to Main Content

Paper Details

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease.
Nat Aging
75
2021
AD, Alzheimer's disease, diltiazem, glimepiride, losartan, metformin, patient, phospho-tau, sildenafil
Author NameAffiliation
Lang LiCollege of Medicine, Ohio State University
Lang LiCollege of Medicine, Ohio State University
  • 1 - 2

Datasets

Release 1.2